Trends in incidence and mortality of lung cancer in Switzerland: Possible explanations and open questions
Authors:
Open Access
- 26 July 2022
- journal article
- research article
- Published by Elsevier in Cancer Epidemiology
- Vol. 80, 102232
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancerAnnals of Translational Medicine, 2018
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General PopulationJournal of Clinical Oncology, 2016
- Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- European cancer mortality predictions for the year 2013Annals of Oncology, 2013
- Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival DataJournal of Nuclear Medicine, 2012
- Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integrationEuropean Respiratory Journal, 2008
- Standard cancer patient population for age standardising survival ratiosEuropean Journal of Cancer, 2004
- The Swiss Health SystemJAMA, 2004
- Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?JAMA, 2000
- Smoking and Carcinoma of the LungBMJ, 1950